Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT07527130
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
o Acceptable forms include:
C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation
Time frame: Baseline reading only
Estimation of areas degree of neuroinflammation determined by the radiologist
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07664696
COVID-19, Coronaviridae Infections
View Trial DetailsNCT07516977
COVID-19, Coronaviridae Infections
Jeonju, South Korea
View Trial DetailsNCT07352072
Bleeding, COVID-19
Copenhagen, Denmark
View Trial DetailsNCT07352462
Bacterial Infections, Bacterial Infections and Mycoses
Lyon, France
View Trial Details